Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Patient dosing starts in first-in-human study of DS-1594 as treatment of AML and ALL

April 9, 2021

Premetastatic niche is prepared via leaky gut in colorectal cancer

April 9, 2021

Stearoyl-CoA-desaturase inhibitor YTX-7739 shows efficacy in glioblastoma mouse models

April 8, 2021

Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma

April 8, 2021

RMC-5552 enters phase I development for relapsed/refractory solid tumors

April 8, 2021

Calico and AbbVie initiate first-in-human study of ABBV-CLS-484

April 8, 2021

Cell Biotech divulges vector constructs for colon cancer

April 8, 2021

First cohort fully enrolled in WWRD Study of AVM-0703

April 8, 2021

Enrollment begins in phase III study of futibatinib in CCA harboring FGFR2 gene rearrangements

April 8, 2021

FDA clears IND for phase II study of MIT-001 as therapy of CCRT-induced oral mucositis in HNSCC

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...